Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Completed

• Conditions: Coronavirus Infection

• Registration Number: NCT04343898
• Lead Sponsor: Brigham and Women's Hospital

Brief Summary

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

Detailed Description

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.

Study Timeline

• Study Start: 2020-04-01
• Study First Submitted: 2020-04-09
• Study First Submitted QC: 2020-04-10
• Study First Posted: 2020-04-13
• Primary Completion: 2020-08-01
• Study Completion: 2023-07-01
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-06
• Last Update Posted: 2023-08-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5154

Inclusion Criteria

Not provided

Exclusion Criteria

-None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
28-Day Mortality	28-days from the day of ICU admission

Secondary Outcome Measures

Name	Time	Method
90-Day Mortality	90-days from the day of ICU admission
60-Day Mortality	60-days from the day of ICU admission

Trial Locations

Locations (1)

Brigham and Women's Hospital; 🇺🇸 Boston, Massachusetts, United States